A 6-year follow-up longitudinal study of 2,981 MDD patients (68) showed the associations of diagnosis and symptoms of depression with the interleukin-6 (IL-6) level, along with the ability of the IL-6 level to predict current MDD and greater symptom severity at follow-up. The gene discussed is IL6; the disease is depressive disorder.